FDA Inspection
CSL Plasma Inc.CSL Plasma Inc. – FDA Inspection, Feb 20, 2013
Record Details
This FDA Inspection record concerns CSL Plasma Inc., with an inspection on February 20, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- CSL Plasma Inc.
- Inspection Date
- February 20, 2013
- Product Type
- Biologics
View Company Profile
ID · 692291ae-2437-4ff2-b5c1-5bcfa87d8d9c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 819182
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CSL Plasma Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| December 16, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 21, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 11, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 15, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 13, 2009 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for CSL Plasma Inc.
- FDA Inspection 1194612 - 2022-12-16
- FDA Inspection 1074767 - 2018-11-21
- FDA Inspection 944254 - 2015-09-11
- FDA Inspection 697816 - 2010-11-15
- FDA Inspection 555841 - 2009-01-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.